GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy

Chemotherapy-induced ovarian dysfunction is a serious adverse effect in premenopausal patients with cancer. Gonadotrophin-releasing hormone analogs (GnRHa) protect ovarian function, but its molecular mechanisms have not yet been determined. In this study, we attempted to determine the previously unk...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaolin, Liu, Sixuan, Chen, Xuan, Huang, Run, Ma, Lisi, Weng, Huaiyu, Yu, Yang, Zong, Xiangyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497541/
https://www.ncbi.nlm.nih.gov/pubmed/34620881
http://dx.doi.org/10.1038/s41523-021-00340-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497541/
https://www.ncbi.nlm.nih.gov/pubmed/34620881
http://dx.doi.org/10.1038/s41523-021-00340-7

Ejemplares similares